CatalàCastellàAnglès

2015

  1. Mur P, Aiza G, Sanz-Pamplona R, González S, Navarro M, Moreno V, Capellá G, Valle L. AMER1 Is a Frequently Mutated Gene in Colorectal Cancer--Letter.. Clin Cancer Res. 2015;21 (21):4985. doi: 10.1158/1078-0432.CCR-15-1756. PubMed PMID:26527806 .

  2. Martínez-Aranda A, Hernández V, Guney E, Muixí L, Foj R, Baixeras N, Cuadras D, Moreno V, Urruticoechea A, Gil M, Oliva B, Moreno F, González-Suarez E, Vidal N, Andreu X, Seguí MA, Ballester R, Castella E, Sierra A. FN14 and GRP94 expression are prognostic/predictive biomarkers of brain metastasis outcome that open up new therapeutic strategies.. Oncotarget. 2015;6 (42):44254-73. doi: 10.18632/oncotarget.5471. PubMed PMID:26497551 PubMed Central PMC4792555.

  3. Zamora-Ros R, Guinó E, Alonso MH, Vidal C, Barenys M, Soriano A, Moreno V. Dietary flavonoids, lignans and colorectal cancer prognosis.. Sci Rep. 2015;5 :14148. doi: 10.1038/srep14148. PubMed PMID:26369380 PubMed Central PMC4572925.

  4. Domènech X, Garcia M, Benito L, Binefa G, Vidal C, Milà N, Moreno V. [Interval cancers and episode sensitivity in population-based screening programmes for colorectal cancer: a systematic review].. Gac Sanit. 2015;29 (6):464-71. doi: 10.1016/j.gaceta.2015.07.002. PubMed PMID:26341155 .

  5. Cebola I, Custodio J, Muñoz M, Díez-Villanueva A, Paré L, Prieto P, Aussó S, Coll-Mulet L, Boscá L, Moreno V, Peinado MA. Epigenetics override pro-inflammatory PTGS transcriptomic signature towards selective hyperactivation of PGE2 in colorectal cancer.. Clin Epigenetics. 2015;7 (1):74. doi: 10.1186/s13148-015-0110-4. PubMed PMID:26207152 PubMed Central PMC4512023.

  6. Schumacher FR, Schmit SL, Jiao S, Edlund CK, Wang H, Zhang B, Hsu L, Huang SC, Fischer CP, Harju JF, Idos GE, Lejbkowicz F, Manion FJ, McDonnell K, McNeil CE, Melas M, Rennert HS, Shi W, Thomas DC, Van Den Berg DJ, Hutter CM, Aragaki AK, Butterbach K, Caan BJ, Carlson CS, Chanock SJ, Curtis KR, Fuchs CS, Gala M, Giovannucci EL, Gogarten SM, Hayes RB, Henderson B, Hunter DJ, Jackson RD, Kolonel LN, Kooperberg C, Küry S, LaCroix A, Laurie CC, Laurie CA, Lemire M, Levine D, Ma J, Makar KW, Qu C, Taverna D, Ulrich CM, Wu K, Kono S, West DW, Berndt SI, Bezieau S, Brenner H, Campbell PT, Chan AT, Chang-Claude J, Coetzee GA, Conti DV, Duggan D, Figueiredo JC, Fortini BK, Gallinger SJ, Gauderman WJ, Giles G, Green R, Haile R, Harrison TA, Hoffmeister M, Hopper JL, Hudson TJ, Jacobs E, Iwasaki M, Jee SH, Jenkins M, Jia WH, Joshi A, Li L, Lindor NM, Matsuo K, Moreno V, Mukherjee B, Newcomb PA, Potter JD, Raskin L, Rennert G, Rosse S, Severi G, Schoen RE, Seminara D, Shu XO, Slattery ML, Tsugane S, White E, Xiang YB, Zanke BW, Zheng W, Le Marchand L, Casey G et al.. Genome-wide association study of colorectal cancer identifies six new susceptibility loci.. Nat Commun. 2015;6 :7138. doi: 10.1038/ncomms8138. PubMed PMID:26151821 PubMed Central PMC4967357.

  7. Costas L, Sequera VG, Quesada P, Altzibar JM, Lope V, Pérez-Gómez B, Benavente Y, Martín V, Casabonne D, Robles C, Llorca J, Moreno-Iribas C, Fernandez-Tardón G, Moreno V, Caballero-Granado FJ, Salas D, Jiménez-Moleón JJ, Marcos-Gragera R, Chirlaque MD, Amiano P, Molina AJ, Castaño-Vinyals G, Aragonés N, Kogevinas M, Pollán M, de Sanjosé S. Hormonal contraception and postmenopausal hormone therapy in Spain: time trends and patterns of use.. Menopause. 2015;22 (10):1138-46. doi: 10.1097/GME.0000000000000487. PubMed PMID:26125537 .

  8. Ríos R, Lupiañez CB, Campa D, Martino A, Martínez-López J, Martínez-Bueno M, Varkonyi J, García-Sanz R, Jamroziak K, Dumontet C, Cayuela AJ, Wętek M, Landi S, Rossi AM, Lesueur F, Reis RM, Moreno V, Marques H, Jurczyszyn A, Andersen V, Vogel U, Buda G, Orciuolo E, Jacobsen SE, Petrini M, Vangsted AJ, Gemignani F, Canzian F, Jurado M, Sainz J. Type 2 diabetes-related variants influence the risk of developing multiple myeloma: results from the IMMEnSE consortium.. Endocr Relat Cancer. 2015;22 (4):545-59. doi: 10.1530/ERC-15-0029. PubMed PMID:26099684 .

  9. Sanz-Pamplona R, Lopez-Doriga A, Paré-Brunet L, Lázaro K, Bellido F, Alonso MH, Aussó S, Guinó E, Beltrán S, Castro-Giner F, Gut M, Sanjuan X, Closa A, Cordero D, Morón-Duran FD, Soriano A, Salazar R, Valle L, Moreno V. Exome Sequencing Reveals AMER1 as a Frequently Mutated Gene in Colorectal Cancer.. Clin Cancer Res. 2015;21 (20):4709-18. doi: 10.1158/1078-0432.CCR-15-0159. PubMed PMID:26071483 PubMed Central PMC4609254.

  10. Rodríguez-Alonso L, Rodríguez-Moranta F, Ruiz-Cerulla A, Lobatón T, Arajol C, Binefa G, Moreno V, Guardiola J. An urgent referral strategy for symptomatic patients with suspected colorectal cancer based on a quantitative immunochemical faecal occult blood test.. Dig Liver Dis. 2015;47 (9):797-804. doi: 10.1016/j.dld.2015.05.004. PubMed PMID:26055489 .

  11. Seguí N, Mina LB, Lázaro C, Sanz-Pamplona R, Pons T, Navarro M, Bellido F, López-Doriga A, Valdés-Mas R, Pineda M, Guinó E, Vidal A, Soto JL, Caldés T, Durán M, Urioste M, Rueda D, Brunet J, Balbín M, Blay P, Iglesias S, Garré P, Lastra E, Sánchez-Heras AB, Valencia A, Moreno V, Pujana MÁ, Villanueva A, Blanco I, Capellá G, Surrallés J, Puente XS, Valle L. Germline Mutations in FAN1 Cause Hereditary Colorectal Cancer by Impairing DNA Repair.. Gastroenterology. 2015;149 (3):563-6. doi: 10.1053/j.gastro.2015.05.056. PubMed PMID:26052075 .

  12. Salas LA, Bustamante M, Gonzalez JR, Gracia-Lavedan E, Moreno V, Kogevinas M, Villanueva CM. DNA methylation levels and long-term trihalomethane exposure in drinking water: an epigenome-wide association study.. Epigenetics. 2015;10 (7):650-61. doi: 10.1080/15592294.2015.1057672. PubMed PMID:26039576 PubMed Central PMC4622514.

  13. García-Esquinas E, Guinó E, Castaño-Vinyals G, Pérez-Gómez B, Llorca J, Altzibar JM, Peiró-Pérez R, Martín V, Moreno-Iribas C, Tardón A, Caballero FJ, Puig-Vives M, Guevara M, Villa TF, Salas D, Amiano P, Dierssen-Sotos T, Pastor-Barriuso R, Sala M, Kogevinas M, Aragonés N, Moreno V, Pollán M. Association of diabetes and diabetes treatment with incidence of breast cancer.. Acta Diabetol. 2016;53 (1):99-107. doi: 10.1007/s00592-015-0756-6. PubMed PMID:25916213 PubMed Central PMC4749645.

  14. Moreno V, Sanz-Pamplona R. Altered pathways and colorectal cancer prognosis.. BMC Med. 2015;13 :76. doi: 10.1186/s12916-015-0307-6. PubMed PMID:25885526 PubMed Central PMC4389340.

  15. Bu P, Wang L, Chen KY, Rakhilin N, Sun J, Closa A, Tung KL, King S, Kristine Varanko A, Xu Y, Huan Chen J, Zessin AS, Shealy J, Cummings B, Hsu D, Lipkin SM, Moreno V, Gümüş ZH, Shen X. miR-1269 promotes metastasis and forms a positive feedback loop with TGF-β.. Nat Commun. 2015;6 :6879. doi: 10.1038/ncomms7879. PubMed PMID:25872451 PubMed Central PMC4399006.

  16. Garcia M, Domènech X, Vidal C, Torné E, Milà N, Binefa G, Benito L, Moreno V. Interval cancers in a population-based screening program for colorectal cancer in catalonia, Spain.. Gastroenterol Res Pract. 2015;2015 :672410. doi: 10.1155/2015/672410. PubMed PMID:25802515 PubMed Central PMC4354714.

  17. Peiró-Pérez R, Salas D, Vallés G, Abad-Fernandez MS, Vidal C, Sanchez-Contador Escudero C, Ascunce-Elizaga N, Zubizarreta R, Pedraz C, Pérez-Gómez B, Navarrete-Muñoz EM, Vioque J, Pollán M, DDM-Spain. Walking, biking or sport: how Spanish women attending breast cancer screening meet physical activity recommendations?. Eur J Public Health. 2015;25 (5):857-63. doi: 10.1093/eurpub/cku248. PubMed PMID:25767095 .

  18. Castaño-Vinyals G, Aragonés N, Pérez-Gómez B, Martín V, Llorca J, Moreno V, Altzibar JM, Ardanaz E, de Sanjosé S, Jiménez-Moleón JJ, Tardón A, Alguacil J, Peiró R, Marcos-Gragera R, Navarro C, Pollán M, Kogevinas M, MCC-Spain Study Group. Population-based multicase-control study in common tumors in Spain (MCC-Spain): rationale and study design.. Gac Sanit. 2015;29 (4):308-15. doi: 10.1016/j.gaceta.2014.12.003. PubMed PMID:25613680 .

  19. Santos C, Sanz-Pamplona R, Nadal E, Grasselli J, Pernas S, Dienstmann R, Moreno V, Tabernero J, Salazar R. Intrinsic cancer subtypes--next steps into personalized medicine.. Cell Oncol (Dordr). 2015;38 (1):3-16. doi: 10.1007/s13402-014-0203-7. PubMed PMID:25586691 .

  20. Kopetz S, Tabernero J, Rosenberg R, Jiang ZQ, Moreno V, Bachleitner-Hofmann T, Lanza G, Stork-Sloots L, Maru D, Simon I, Capellà G, Salazar R. Genomic classifier ColoPrint predicts recurrence in stage II colorectal cancer patients more accurately than clinical factors.. Oncologist. 2015;20 (2):127-33. doi: 10.1634/theoncologist.2014-0325. PubMed PMID:25561511 PubMed Central PMC4319631.

  21. Zamora-Ros R, Shivappa N, Steck SE, Canzian F, Landi S, Alonso MH, Hébert JR, Moreno V. Dietary inflammatory index and inflammatory gene interactions in relation to colorectal cancer risk in the Bellvitge colorectal cancer case-control study.. Genes Nutr. 2015;10 (1):447. doi: 10.1007/s12263-014-0447-x. PubMed PMID:25488145 PubMed Central PMC4259879.

  22. Garcia M, Milà N, Binefa G, Benito L, Gonzalo N, Moreno V. Fecal hemoglobin concentration as a measure of risk to tailor colorectal cancer screening: are we there yet?. Eur J Cancer Prev. 2015;24 (4):321-7. doi: 10.1097/CEJ.0000000000000090. PubMed PMID:25370684 .

  23. Campa D, Martino A, Varkonyi J, Lesueur F, Jamroziak K, Landi S, Jurczyszyn A, Marques H, Andersen V, Jurado M, Brenner H, Petrini M, Vogel U, García-Sanz R, Buda G, Gemignani F, Ríos R, Vangsted AJ, Dumontet C, Martínez-López J, Moreno MJ, Stępień A, Wątek M, Moreno V, Dieffenbach AK, Rossi AM, Butterbach K, Jacobsen SE, Goldschmidt H, Sainz J, Hillengass J, Orciuolo E, Dudziński M, Weinhold N, Reis RM, Canzian F. Risk of multiple myeloma is associated with polymorphisms within telomerase genes and telomere length.. Int J Cancer. 2015;136 (5):E351-8. doi: 10.1002/ijc.29101. PubMed PMID:25066524 .